Research article · 30 Jun 2023
Conference abstractPublished 29 Apr 2019
Ventricular assist devices: An Indian experience
Max Super Specialty Hospital, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Ventricular assist devices are an established therapy for advanced heart failure. Continuous flow devices are representing an innovative design with potential for small size and greater reliability by simplification of pumping mechanism. A small percentage of patients who are too ill to wait for donor heart Left Ventricular Assist Device (LVAD) offers lifesaving therapy in them. We started our program in Feb 2015. So far, we have put 17 LVADs in 16 patients. Out of 17, five were Heart Mate II and four were Heart Ware and 8 were Heart Mate III. Twelve patients were male and four were females. Twelve patients had dilated cardiomyopathy and four had ischemic cardiomyopathy. Average ICU stay was 5 days and hospital stay was 18 days. One had thrombosis of device on post-operative day three which required exchange of the device. One of them died on postoperative day 12 because of ventricular arrhythmia and right ventricular failure. In one patient device was removed as bridge to recovery after 18 months. One patient was bridge to transplant. A LVAD provides effective hemodynamic support in patients with end stage heart failure with improved functional status and quality of life. LVAD is the only alternative that offers a ray of hope to thousands of patients whose hearts are too weak to survive and those waiting for a heart transplant. Improvements in device design, along with advances in surgical and medical management have allowed VAD patients to return home, to work, and to their communities, with excellent quality of life.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Opinion · 26 Apr 2023
Optimizing Anticoagulation Therapy in Left Ventricular Assist Device Patients
Mini review · 30 Mar 2023
When a Patient Requires a Ventricular Assist Device to be Implanted, the Optimal Time for Tooth Extraction: A Study of a Cohort Over Time
Conference abstract · 21 Sep 2022
Mechanism of myocardial damage cardiac cell therapy and its trials cell-derived bio medicals strategies to promote cardio-myocyte proliferation optimization of medical therapy and left ventricular assist device conclusio
Commentary · 19 Jun 2022
Looking to the Future of Ventricular Assist Devices in Pediatric Cardiomyopathy
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Kewal Krishan”
